Vaccines alliance signs $5 mln advance deal for Merck's Ebola shot
January 20, 2016 at 03:30 AM EST
DAVOS/LONDON, Jan 20 (Reuters) - The Gavi global alliance for vaccines and immunisation group signed a $5 million advance purchase commitment on Wednesday to buy a vaccine being developed by Merck to protect against future outbreaks of the deadly Ebola virus.
